An Interview with Jason Tardio, Chief Operating Officer of Ovid Therapeutics
Episode 82, Jun 06, 2023, 04:17 PM
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Jason Tardio, chief operating officer at Ovid Therapeutics,